TY  - JOUR
AU  - Reungwetwattana, Thanyanan
AU  - Nakagawa, Kazuhiko
AU  - Cho, Byoung Chul
AU  - Cobo, Manuel
AU  - Cho, Eun Kyung
AU  - Bertolini, Alessandro
AU  - Bohnet, Sabine
AU  - Zhou, Caicun
AU  - Lee, Ki Hyeong
AU  - Nogami, Naoyuki
AU  - Okamoto, Isamu
AU  - Leighl, Natasha
AU  - Hodge, Rachel
AU  - McKeown, Astrid
AU  - Brown, Andrew P
AU  - Rukazenkov, Yuri
AU  - Ramalingam, Suresh S
AU  - Vansteenkiste, Johan
PY  - 2018
DO  - 10.1200/JCO.2018.78.3118
UR  - http://hdl.handle.net/10668/12878
T2  - Journal of clinical oncology : official journal of the American Society of Clinical Oncology
AB  - Purpose We report CNS efficacy of osimertinib versus standard epidermal growth factor receptor ( EGFR) tyrosine kinase inhibitors (TKIs) in patients with untreated EGFR-mutated advanced non-small-cell lung cancer from the phase III FLAURA study....
LA  - en
PB  - American Society of Clinical Oncology
KW  - Neoplasm Metastasis
KW  - Lung Neoplasms
KW  - Progression-Free Survival
KW  - Adrenal Cortex Hormones
KW  - Tyrosine Protein Kinase Inhibitors
KW  - Carcinoma, Non-Small-Cell Lung
KW  - Gefitinib
KW  - Erlotinib Hydrochloride
KW  - Odds Ratio
KW  - Progression-Free Survival
TI  - CNS Response to Osimertinib Versus Standard Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.
TY  - research article
ER  -